Postmenopausal endometriosis
This review summarizes current literature on postmenopausal endometriosis, covering epidemiology, pathogenesis, treatment principles, and the risk of malignancy and recurrence with menopausal hormone therapy.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This paper reviews postmenopausal endometriosis as an estrogen-dependent condition that is often presumed to “fade” with menopause, but for which clinical recurrences, de novo cases, and increasing evidence of persistence are reported. Using narrative synthesis of historical case reports, retrospective epidemiology, and mechanistic hypotheses, it estimates that prevalence in peri- and postmenopausal women is around 2–5% (with examples from surgical series, including a German analysis of 42,079 cases), and discusses uncertainty about whether postmenopausal disease represents continuation versus new onset, with proposed roles for extra-glandular estrogen synthesis and an estrogen “threshold/persistent loop” in ectopic tissue. Limitations are that the paper is not a single original study and relies on heterogeneous evidence, and it notes that pathophysiology remains incompletely understood. It also relates to endometriosis management by summarizing randomized trial data and guideline recommendations on menopausal hormone therapy and by describing case reports linking tamoxifen to endometriosis and endometrial carcinoma, while discussing how endometriotic lesions remain biologically active in low-estrogen postmenopausal conditions. This paper is centrally about endometriosis — specifically, it focuses on postmenopausal endometriosis, its epidemiology, pathogenesis, and hormonal associations.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (40)
- A Review of the Epigenetic Contributions to Endometriosis via openalex
- Aromatase inhibitors in the treatment of endometriosis via openalex
- Beyond Endometriosis Genome-Wide Association Study: From Genomics to Phenomics to the Patient via openalex
- Clinical anatomy of pelvic pain in women via openalex
- EMAS position statement: Managing the menopause in women with a past history of endometriosis via openalex
- Endometriosis via openalex
- Endometriosis after Menopause via openalex
- Endometriosis after menopause: physiopathology and management of an uncommon condition via openalex
- Endometriosis: a premenopausal disease? Age pattern in 42,079 patients with endometriosis via openalex
- Endometriosis-Associated Ovarian Cancer via openalex
- Endometriosis-associated ovarian cancer: What have we learned so far? via openalex
- Endometriosis in menopause: a single institution experience via openalex
- External Endometriosis in 801 Operated Patients via openalex
- Factors associated with ovarian endometriosis malignancy and its recurrence in Chinese women via openalex
- Hormone therapy for endometriosis and surgical menopause via openalex
- Long-Term Follow-Up after Surgical Management for Atypical Endometriosis: A Series of Nine Cases via openalex
- Ovarian and Extraovarian Endometriosis-Associated Cancer via openalex
- Pathogenomics of Endometriosis Development via openalex
- Persistent bilateral ureteral obstruction secondary to endometriosis despite treatment with an aromatase inhibitor via openalex
- Polypoid endometriosis: a mimic of malignancy via openalex
- Postmenopausal endometriosis via openalex
- Potential role of aromatase inhibitors in the treatment of endometriosis via openalex
- Recent Advances in Gene Therapy of Endometriosis via openalex
- Recent insights on the genetics and epigenetics of endometriosis via openalex
- Recurrence of endometriosis in women with bilateral adnexectomy (with or without total hysterectomy) who received hormone replacement therapy via openalex
- Risk factors of epithelial ovarian carcinomas among women with endometriosis: a systematic review via openalex
- SIGNIFICANT POSTMENOPAUSAL ENDOMETRIOSIS via openalex
- The risk of extra-ovarian malignancies among women with endometriosis: A systematic literature review and meta-analysis via openalex
- Three cases of clear‐cell adenocarcinoma arising from endometrioma during hormonal treatments via openalex
- Treatment of Severe Postmenopausal Endometriosis With an Aromatase Inhibitor via openalex
- W2888053874 via openalex
- W2145213731 via openalex
- W2161226706 via openalex
- W2272134694 via openalex
- W2917177127 via openalex
- W2039605313 via openalex
- W2033166710 via openalex
- W2009742179 via openalex
- W2319816600 via openalex
- W1969234722 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00